Assenagon Asset Management S.A. Sells 15,744 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Assenagon Asset Management S.A. cut its stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 12.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 108,264 shares of the company's stock after selling 15,744 shares during the period. Assenagon Asset Management S.A. owned about 0.57% of USANA Health Sciences worth $3,886,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in USNA. Safe Harbor Fiduciary LLC bought a new stake in USANA Health Sciences in the third quarter valued at approximately $30,000. KBC Group NV boosted its position in USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock valued at $40,000 after buying an additional 519 shares during the period. Centiva Capital LP bought a new stake in USANA Health Sciences in the 3rd quarter worth $213,000. Quest Partners LLC bought a new stake in USANA Health Sciences in the 3rd quarter worth $250,000. Finally, Exchange Traded Concepts LLC raised its stake in shares of USANA Health Sciences by 4.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock valued at $292,000 after acquiring an additional 322 shares during the last quarter. Institutional investors own 54.25% of the company's stock.

Insider Activity at USANA Health Sciences

In related news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on USNA shares. StockNews.com upgraded USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Saturday, December 28th. DA Davidson increased their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a "neutral" rating in a research note on Thursday, January 2nd.

USANA Health Sciences Stock Performance

Shares of USNA traded up $0.19 during mid-day trading on Tuesday, reaching $34.21. The stock had a trading volume of 71,232 shares, compared to its average volume of 102,175. The business has a fifty day moving average of $36.91 and a 200 day moving average of $38.67. The firm has a market cap of $651.95 million, a price-to-earnings ratio of 12.09, a PEG ratio of 0.92 and a beta of 0.89. USANA Health Sciences, Inc. has a 12 month low of $31.44 and a 12 month high of $52.75.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the prior year, the business posted $0.59 EPS. On average, research analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.